China BE study [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-08-29 10:34  – Posting: # 20529
Views: 737

Hi Ajit,

please follow the Forum’s Policy.

» Can we submit USFDA approved ANDA dossier to CFDA for drug Registration

You can submit everything but the chance for acceptance is close to nil.

» […] we need to do Fresh BE study in chinese population

Correct. Like most jurisdictions the National Medical Products Administration, Center for Drug Evaluation (NMPA, CDE) – formerly the China Food and Drug Administration or CFDA – requires the local reference product in the study.* Only if the innovator’s product is not approved in China, one can use the major market’s corresponding product.

There are some more differences to the FDA’s requirements to observe:


Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
20,008 posts in 4,231 threads, 1,377 registered users;
online 12 (1 registered, 11 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 00:06 CET

The plural of anecdote is data.    Raymond Wolfinger

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5